About Us
Korsana was founded with the mission to advance precision-engineered therapies, designed to address some of the biggest unmet needs in medicine. We are committed to delivering better medicines to patients suffering from devastating neurodegenerative diseases, starting with Alzheimer’s disease.
Leadership Team
A seasoned leadership team with a proven track record to rapidly build and scale organizations that advance best-in-class therapies.
Jonathan Violin
Chief Executive Officer
Kyle Breidenstine
SVP, Finance
Maddy Zeylikman
General Counsel
Board of Directors
Andrew Gottesdiener
Director
Partner, Venrock
Partner, Venrock
Tomas Kiselak
Chairman
Founding Partner, Fairmount Funds Management LLC
Founding Partner, Fairmount Funds Management LLC
Nilesh Kumar
Director
Head of Biotech Private Investments, Wellington Management
Head of Biotech Private Investments, Wellington Management
Michelle Pernice
Director
Operating Partner, Fairmount Funds Management LLC
Operating Partner, Fairmount Funds Management LLC
Nimish Shah
Director
Partner, Venrock
Partner, Venrock
Jonathan Violin
Chief Executive Officer
Cariad Chester
Observer
Managing Partner, TCGX
Managing Partner, TCGX
Meg Krench
Observer
Principal, Sanofi Ventures
Principal, Sanofi Ventures